Literature DB >> 31663997

Cochlear Enhancement May Precede Cochlear Obliteration After Vestibular Schwannoma Excision.

Isaac D Erbele1, Laura S Miller2, Gauri Mankekar1, Christian E Morel2, Dwayne T Anderson2, Leslie S Son3,1, Moises A Arriaga1.   

Abstract

OBJECTIVE: Cochlear obliteration after vestibular schwannoma excision has been noted, with implications on cochlear implantation. Early postoperative cochlear enhancement with gadolinium on magnetic resonance imaging (MRI) has also been observed. Timing of enhancement and association with obliteration is described here. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center, ambulatory. PATIENTS: Patients receiving vestibular schwannoma excision surgery by the senior author performed at one institution between January 2015 and July 2017 with postoperative MRIs INTERVENTION:: Diagnostic. MAIN OUTCOME MEASURE(S): The imaging characteristics on postoperative MRIs examined were loss of fluid signal on postoperative T2 images and cochlear enhancement on gadolinium enhanced T1 images. In the patients receiving labyrinthine sparing procedures, presence of postoperative hearing was evaluated.
RESULTS: Of the 42 patients evaluated, 24 received the translabyrinthine approach and 18 received a labyrinth sparing surgery. Twenty-nine had evidence of cochlear enhancement on T1 with gadolinium contrast, and 27 had evidence of cochlear obliteration on T2 images. The odds ratio of patients with cochlear enhancement having obliteration was 30.0:1 (p < 0.0001). Intense cochlear enhancement (n = 21) appeared a median of 163 days after surgery, and complete or near complete obliteration (n = 18) appeared a median of 480 days after surgery, a statistically significant difference (p < 0.001). Within the labyrinth sparing group, there was no statistically significant association between hearing loss and cochlear obliteration or enhancement.
CONCLUSIONS: Cochlear enhancement is correlated with cochlear obliteration and may precede it.

Entities:  

Mesh:

Year:  2020        PMID: 31663997     DOI: 10.1097/MAO.0000000000002498

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Letter to the Editor: "Cochlear Patency after Translabyrinthine and Retrosigmoid Vestibular Schwannoma Surgery".

Authors:  Isaac D Erbele; Dwayne T Anderson; Moisés A Arriaga
Journal:  J Int Adv Otol       Date:  2021-05       Impact factor: 1.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.